CareMax Inc
NASDAQ:CMAX
Relative Value
The Relative Value of one CMAX stock under the Base Case scenario is 598.86 USD. Compared to the current market price of 3.57 USD, CareMax Inc is Undervalued by 99%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
CMAX Competitors Multiples
CareMax Inc Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
US |
C
|
CareMax Inc
NASDAQ:CMAX
|
13.4m USD | 0 | -0 | 0.4 | 0.3 | |
US |
Cigna Corp
NYSE:CI
|
104.4B USD | 0.5 | 20.2 | 10.4 | 13.8 | ||
US |
C
|
Cigna Group
XMUN:CGN
|
96.9B EUR | 0.5 | 20 | 10.3 | 13.7 | |
US |
CVS Health Corp
NYSE:CVS
|
87.2B USD | 0.2 | 10.5 | 8.9 | 8.9 | ||
DE |
Fresenius Medical Care AG
XMUN:FME
|
22.7B EUR | 1.2 | 45.6 | 10.6 | 25.1 | ||
US |
Laboratory Corporation of America Holdings
NYSE:LH
|
17B USD | 1.4 | 39.2 | 11.9 | 18 | ||
DE |
F
|
Fresenius SE & Co KGaA
XETRA:FRE
|
15.8B EUR | 0.7 | -26.5 | 10.1 | 22.6 | |
US |
Quest Diagnostics Inc
NYSE:DGX
|
15.3B USD | 1.7 | 18.2 | 10.8 | 14.6 | ||
DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.6B EUR | 0.6 | 23.3 | 6.9 | 16.4 | |
US |
DaVita Inc
NYSE:DVA
|
12.3B USD | 1 | 17.9 | 8.6 | 12.6 | ||
US |
Oak Street Health Inc
NYSE:OSH
|
9.5B USD | 4.4 | -18.6 | -23.3 | -21.5 |